The Therapeutic Effects of Extracorporeal Shock Wave Therapy (ESWT) on the Rotator Cuff Lesions with Shoulder Stiffness: A Prospective Randomized Study

Table 1

Demographic profiles for the two groups.

	ESWT group	Sham group	value
Gender	9 men, 10 women	3 men, 15 women	0.527
Age	52.0 (50.5, 60.5)	51.0 (49.0, 54.0)	0.709
Nontear tendinopathy/partial tear	11/8	14/4	0.197
Subacromial steroid injection^#	8	7	0.842
Affected shoulder	7 right, 12 left	11 right, 7 left	0.024
Affected shoulder as dominant limb	8 (42.1%)	11 (61.1%)	0.280
BMI	24.5 (21.8, 26.6)	23.1 (22.3, 25.7)	0.688
Medical comorbidities	2 men, 1 woman	0	0.425

BMI: body mass index; ESWT: extracorporeal shockwave therapy. Medical comorbidities included diabetes, coronary artery disease, end-stage renal disease, and liver cirrhosis. ^#Subacromial steroid injection performed more than 3 weeks before the intervention.